Exogenous surfactant is typically administered shortly after birth in premature infants who are at high risk for or are diagnosed with RDS. Some guidelines also recommend prophylactic administration in extremely low birth weight infants. It can also be used in older children with conditions like Acute Respiratory Distress Syndrome (ARDS) or meconium aspiration syndrome.
